DIANA BRATCHER: Open Payments
NPI 1326004946 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 46 payments from 21 companies in 2025. Trend: 2023 $242 · 2024 $790 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $209 |
| AstraZeneca Pharmaceuticals LP | 4 | $109 |
| ABBVIE INC. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Incyte Corporation | 2 | $52 |
| Genentech USA, Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $34 |
Products named: LIBTAYO, TAGRISSO, VENCLEXTA, KEYTRUDA, LYNOZYFIC, DATROWAY, KISQALI, EPKINLY.
Industry payments across KY — which companies pay providers there.
